Comparative in vitro and ex-vivo myelotoxicity of aflatoxins B1 and M1 on haematopoietic progenitors (BFU-E, CFU-E, and CFU-GM): Species-related susceptibility

Toxicology in Vitro

Volumn 24, Issue 1, 2010, Pages 217-223

  Roda, E ^a   Coccini, T ^b   Acerbi, D ^b   Castoldi, A F ^b   Manzo, L ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b IRCCS   (Italy)

Author keywords

Aflatoxin; Bone marrow; Clonogenic assay; Human; Mouse

Indexed keywords

AFLATOXIN B1; AFLATOXIN M1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MARROW TOXICITY; BURST FORMING UNIT E; CELL PROLIFERATION; CLONOGENIC ASSAY; COLONY FORMING UNIT E; COLONY FORMING UNIT GM; CONTROLLED STUDY; ERYTHROID PRECURSOR CELL; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; SPECIES COMPARISON;

AFLATOXIN B1; AFLATOXIN M1; ANIMALS; BLOOD CELL COUNT; BODY WEIGHT; BONE MARROW CELLS; CELL LINEAGE; CELL SEPARATION; COLONY-FORMING UNITS ASSAY; ERYTHROID PRECURSOR CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTES; MALE; MICE; MUTAGENS; SPECIES SPECIFICITY;

ANIMALIA; MURINAE; MUS;

EID: 72049087732     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2009.09.005     Document Type: Article

References (40)

1. Amess J. Haematotoxicology. In: Ballantyne B., Marrs T., and Turner P. (Eds). General and Applied Toxicology vol. 1 (1993), Macmillan Stockon Press, New York 839-867
2. Anwar W.A., Khalil M.M., and Wild C.P. Micronuclei, chromosomal aberrations and aflatoxin-albumin adducts in experimental animals after exposure to aflatoxin B1. Mutation Research 322 (1994) 61-67
3. Barta I., Adamkova M., Petr T., and Bartova J. Dose and time dependence of chromosomal aberration yields of bone marrow cells in male Chinese hamster after a single i.p. injection of aflatoxin B1. Mutation Research 244 (1990) 189-195
4. Bloom J.C. Principles of hematotoxicology: laboratory assessment and interpretation of data. Toxicologic Pathology 21 (1993) 130-134
5. Bondy G.S., and Pestka J.J. Immunomodulation by fungal toxin. Journal of Toxicology and Environmental Health (Part B) 3 (2000) 109-143
6. Chen C.Y., Li W.J., and Peng K.Y. Determination of Aflatoxin M1 in milk and milk powder using high-flow solid-phase extraction and liquid chromatography-tandem mass spectrometry. Journal of Agricultural and Food Chemistry 53 (2005) 8474-8480
7. Corrier D.E. Mycotoxicosis: mechanism of immunosuppression. Veterinary Immunology and Immunopathology 30 (1991) 73-87
8. Cukrova V., Langrova E., and Akao M. Effects of aflatoxin B1 on myelopoiesis in vitro. Toxicology 70 (1991) 203-211
9. Cukrova V., Kurita N., and Akao M. An early effect of aflatoxin B1 administered in vivo on the growth of bone marrow CFU-GM and the production of some Cytokines in rats. Mycopathology 120 (1992) 113-119
10. Cukrova V., Kurita N., and Akao M. Alterations in the growth and cycling status of granulocyte-monocyte colony forming units (CFU-GM) in rats injected single doses of aflatoxin B1. Neoplasma 39 (1992) 93-96
11. Dugyala R.R., Kim Y.-W., and Sharma R.P. Effects of aflatoxin B1 and T-2 toxin on the granulocyte-macrophage progenitor cells in mouse bone marrow cultures. Immunopharmacology 27 (1994) 57-65
12. Eaton L.D., and Gallhager E.P. Mechanism of aflatoxin carcinogenesis. The Annual Review of Pharmacology and Toxicology 34 (1994) 135-172
13. European Commission (EC), 2006. Commission Decision of 12 July 2006 on special conditions governing certain foodstuffs imported from certain third countries due to contamination risks of these products by aflatoxins (2006/504/EC). Official Journal of the European Union, L199, 21-39.
14. European Commission (EC), 2007. Commission Decision of 1 August 2007 amending Decision 2006/504/EC on special conditions governing certain foodstuffs imported from certain third countries due to contamination risks of these products by aflatoxins as regards almonds and derived products originating in or consigned from the United States of America (2007/563/EC). Official Journal of the European Union, L215, 18-20.
15. European Food Safety Authority (EFSA), 2007. Opinion of the Scientific Panel on contaminants in the food chain on a request from the Commission related to the potential increase of consumer health risk by a possible increase of the existing maximum levels for aflatoxins in almonds, hazelnut, and pistachios and derived products. (Question No. EFSA-Q-2006-174). Adopted on 25 January 2007. The EFSA Journal 446, 1-127.
16. Fink-Gremmels J. Mycotoxins: their implications for human and animal health. Veterinary Quarterly 21 (1999) 115-120
17. Gribaldo L. Haematotoxicology: scientific basis and regulatory aspects. ATLA-Alternatives to Laboratory Animals 30 Suppl. 2 (2002) 111-113
18. International Agency for Research on Cancer (IARC). Aflatoxins. IARC Monographs on Evaluation of Carcinogenic Risks in Humans 56 (1993) 245-395
19. International Agency for Research on Cancer (IARC). Some traditional herbal medicines, some mycotoxins, naphtalene and styrene. IARC Monographs on Evaluation of Carcinogenic Risks in Humans 82 (2002) 1-556
20. Ito Y., Ohnishi S., and Fujie K. Chromosome aberrations induced by aflatoxin B1 in at bone marrow cells and suppression by green tea. Mutation Research 222 (1989) 253-261
21. Kirbi G.M., Wolf C.F., Neal G.E., Judah D.J., Henderson C.J., Srivatanakul P., and Wild C.P. In vitro metabolism of aflatoxin B1 by normal and tumorous liver from Thailand. Carcinogenesis 14 (1993) 2613-2620
22. Kirbi G.M., Chemin I., Montesano R., Chisari F.V., Lang M.A., and Wild C.P. Induction of specific cytochrome P450s involved in aflatoxin B1 metabolism in hepatitis B virus transgenic mice. Molecular Carcinogenesis 11 (1994) 74-80
23. Malerba I., Castoldi A.F., Parent-Massin D., and Gribaldo L. In vitro Myelotoxicity of Propanil and 3,4-dichloroaniline on murine and human CFU-E/BFU-E progenitors. Toxicological Sciences 69 (2002) 433-438
24. Malerba I., Casati S., Diodovich C., Parent-Massin D., and Gribaldo L. Inhibition of CFU-E/BFU-E and CFU-GM colony growth by cyclophosphamide, 5-fluorouracil and taxol: development of a high throughput in vitro method. Toxicology in vitro 18 (2004) 293-300
25. Neal G.E., Eaton D.L., Judah D.J., and Verma A. Metabolism and toxicity of aflatoxins M1 and B1 in human-derived in vitro systems. Toxicology and Applied Pharmacology 151 (1998) 152-158
26. Oswald I.P., Marin D.E., Bouhet S., Pinton P., Taranu I., and Accensi F. Immunotoxicological risk of mycotoxins for domestic animals. Food Additives and Contaminants 22 (2005) 354-360
27. Parchment R.E. Alternative testing system for evaluating non-carcinogenic, hematologic toxicity. Environmental Health Perspectives 106 Suppl. 2 (1998) 541-557
28. Parent-Massin D. Relevance of clonogenic assays in hematotoxicology. Cell Biology and Toxicology 17 (2001) 87-94
29. Pessina A., Albella B., Bueren J., Brantom P., Casati S., Croera C., Gagliardi G., Foti P., Parrent-Massin D., Sibiri Y., and Van Den Heuvel R. Prevalidation of a model for predicting acute neutropenia by colony-forming unit granulocyte/macrophage (CFU-GM) assay. Toxicology in vitro 15 (2001) 729-740
30. Pessina A., Albella B., Bayo M., Bueren J., Brantom P., Casati S., Croera C., Parchment R., Parent-Massin D., Schoeters G., Sibiri Y., Van Den Heuvel R., and Gribaldo L. In vitro tests for haematotoxicity: prediction of drug-induced myelosuppression by the CFU-GM assay. ATLA-Alternatives to Laboratory Animals 30 (2002) 75-79
31. Pessina A., Malerba I., and Gribaldo L. Hematotoxicity testing by cell clonogenic assay in drug development and preclinical trials. Current Pharmaceutical Design 11 (2005) 1055-1065
32. Pitt J.I. Toxigenic fungi: which are important?. Medical Mycology 38 Suppl. 1 (2000) 17-22
33. Raj H.G., Kohli E., Rohil V., Dwarakanath B.S., Parmar V.S., Malik S., Adhikari J.S., Tyagi Y.K., Goel S., Gupta K., Bose M., and Olsen C.E. Acetoxy-4-methylcoumarins confer differential protection from aflatoxin B1-induced micronuclei and apoptosis in lung and bone marrow cells. Mutation Research 494 (2001) 31-40
34. Raney K.D., Meyer D.J., Ketterer B., Harris T.M., and Guengerich F.P. Glutathione conjugation of aflatoxin B1 exo- and endo-epoxides by rat and human glutathione S-transferases. Chemical Research in Toxicology 5 (1992) 470-478
35. Sharma R.R. Immunotoxicity of mycotoxins. Journal of Dairy Science 76 (1993) 892-897
36. Stephenson J.R., Axelrad A.A., McLeod D.L., and Shreeve M.M. Induction of colonies of hemoglobin-synthesising cells by erythropoietin in vitro. Proceedings of the National Academy of Sciences of the United States of America 68 (1971) 1542-1546
37. Tepperman A.D., Curtis J.E., and McCulloch E.A. Erythropoietic colonies in cultures o human marrow. Blood 44 (1974) 659-669
38. Tung H.-T., Cook F.W., Wyatt R.D., and Hamilton P.B. The anaemia caused by aflatoxin. Poultry Sciences 54 (1975) 1962-1969
39. World Health Organization (WHO), 2006. Evaluation of certain food contaminants (sixth-fourth report of the Joint FAO/WHO Expert Committee on Food Additives). World Health Organization (WHO) Technical Report Series No. 930.
40. Wild C.P., Hasegawa R., Barraud L., Chutimataewin S., Chapot B., Ito N., and Montesano R. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans. Cancer Epidemiology Biomarkers & Prevention 5 (1996) 179-189